Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd. (688505.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 7.70

From 52W high−6.37%

Volume8.01M

Market capCNY 8.69B

P/E (TTM)−55.2x

P/S (TTM)12.2x

Div yield—

Key dataSep 18, 2026

Open

CNY 7.70

From 52W high

−6.37%

Volume

8.01M

Market cap

CNY 8.69B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−83.2x

P/E (TTM)

−55.2x

RSI (14)

46.4

MomentumView details →

1D Return

−3.01%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−55.2x

EV/EBITDA

−83.2x

EV/Sales

10.5x

P/S (TTM)

12.2x

P/B (TTM)

4.0x

ProfitabilityView details →

Gross Margin

89.99%

Net Margin

−23.27%

EBITDA Margin

−12.64%

ROE (TTM)

−7.18%

ROA (TTM)

−6.50%

Asset Turnover

0.28x

GrowthView details →

Revenue YoY

−11.69%

EPS YoY

—

FCF YoY

+202.50%

Revenue CAGR 3Y

−12.71%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−3.01%

YTD Return

—

1Y Return

—

RSI (14)

46.4

vs 50D SMA

−1.62%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

7.46x

Quick Ratio

7.28x

Div Yield

—

Div Rate

—

Div Growth 1Y

−66.67%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

666.99M

Net Income (TTM)

−126.38M

Op. CF (TTM)

161.30M

Latest newsMore news →

Fudan Zhangjiang Bio-Pharmaceutical reported interim results for the six months ended June 2026, with net profit of 36.895 million RMB, up 545% year-on-year.37d ago

Similar companies

美诺华603538.SH SSY Group Limited02005.HK 华北制药600812.SH 太极集团600129.SH 马应龙600993.SH 上海谊众688091.SH Find similar companies →

Latest newsMore news →

Fudan Zhangjiang Bio-Pharmaceutical reported interim results for the six months ended June 2026, with net profit of 36.895 million RMB, up 545% year-on-year.37d ago